ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATHRYN HINES MD

Internal Medicine

608

$33.3K

89
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

RONALD KILLAM M.D.

Internal Medicine

19,070

$1.09M

616
373 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

HIRAM TAVAREZ M.D.

Internal Medicine

7,178

$449K

466
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

JOSE VAZQUEZ M.D.

Internal Medicine

13,888

$1.59M

706
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$115
Average prescription price

Avg: $67

RICARDO CUADRA MD

Internal Medicine

18,985

$1.08M

838
625 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

WILLIAM CHRISTENSEN M.D.

Internal Medicine

10,402

$562K

341
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

DANIEL SMITH M.D.

Internal Medicine

10,303

$738K

814
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

NGUYEN PHAN M.D.

Internal Medicine

1,776

$106K

119
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

RONALDO FACTORIZA M.D.

Internal Medicine

23,247

$1.62M

828
716 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

DARSHAN GANDHI M.B.B.S.

Internal Medicine

388

$28.5K

69
51 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

GEORGE MARKUS M.D.

Internal Medicine

9,018

$538K

429
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

RICARDO ADAMES M.D.

Internal Medicine

21,543

$1.19M

723
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

GEORGE SAIKIN MD

Internal Medicine

9,287

$492K

376
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

JOE ETTER D.O.

Internal Medicine

13,940

$893K

531
394 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

AMY SIMPSON M.D.

Internal Medicine

7,321

$387K

276
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

ALICIA ROMERO MD

Internal Medicine

781

$88.1K

81
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $67

HUSSAMADDIN AL KHADOUR M.D.

Internal Medicine

12,028

$712K

375
190 are 65+

17%
patients receiving schedule two controlled substances

Avg: 1%

50%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

KATHLEEN WEINDORFF MD

Internal Medicine

9,921

$669K

461
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

COURTNEY MCCRAY MD

Internal Medicine

449

$94.2K

72
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$210
Average prescription price

Avg: $67

JAIME GOMEZ M.D.

Internal Medicine

1,063

$79.9K

81
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $67

ATULKUMAR PATEL MD

Internal Medicine

5,155

$248K

227
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

KHURSHID KHAN M.D.

Internal Medicine

7,159

$262K

363
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$37
Average prescription price

Avg: $67

BALJIT KAUR MD

Internal Medicine

503

$22.4K

56
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $67

LAKHU ROHRA MD

Internal Medicine

2,651

$136K

128
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

MARSHALL MORRISON M.D.

Internal Medicine

18,665

$1.04M

694
616 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank